These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23188179)

  • 1. Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challenges.
    Vitoria M; Vella S; Ford N
    Curr Opin HIV AIDS; 2013 Jan; 8(1):12-8. PubMed ID: 23188179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites.
    Jordan MR; Bennett DE; Bertagnolio S; Gilks CF; Sutherland D
    Antivir Ther; 2008; 13 Suppl 2():15-23. PubMed ID: 18575188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance.
    Bennett DE; Bertagnolio S; Sutherland D; Gilks CF
    Antivir Ther; 2008; 13 Suppl 2():1-13. PubMed ID: 18578063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of HIV in resource limited settings.
    McCutchan JA
    Curr Opin Infect Dis; 2009 Oct; 22(5):464-70. PubMed ID: 19730283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethical and programmatic challenges in antiretroviral scaling-up in Malawi: challenges in meeting the World Health Organization's "Treating 3 million by 2005" initiative goals.
    Muula AS
    Croat Med J; 2004 Aug; 45(4):415-21. PubMed ID: 15311413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public-sector ART in the Free State Province, South Africa: community support as an important determinant of outcome.
    Wouters E; Van Damme W; Van Loon F; van Rensburg D; Meulemans H
    Soc Sci Med; 2009 Oct; 69(8):1177-85. PubMed ID: 19692165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early initiation of antiretroviral therapy and universal HIV testing in sub-Saharan Africa: has WHO offered a milestone for HIV prevention?
    Menon S
    J Public Health Policy; 2010 Dec; 31(4):385-400. PubMed ID: 21119646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiretroviral treatment in low-resource settings: what has changed in the last 10 years and what needs to change in the coming years?
    Mehta M; Semitala F; Lynen L; Colebunders R
    Expert Rev Anti Infect Ther; 2012 Nov; 10(11):1287-96. PubMed ID: 23241186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV in the tropics: staging in the resource-limited setting.
    Varughese JK; Rosenberg MG; Kim K
    Curr Opin Infect Dis; 2012 Oct; 25(5):477-83. PubMed ID: 22744319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settings.
    Bartlett JA; Hornberger J; Shewade A; Bhor M; Rajagopalan R
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(4):253-68. PubMed ID: 19721103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on the pediatric HIV/AIDS pandemic: catalyzing access of children to care and treatment.
    Kline MW
    Pediatrics; 2006 Apr; 117(4):1388-93. PubMed ID: 16585337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings.
    Gilks CF; Crowley S; Ekpini R; Gove S; Perriens J; Souteyrand Y; Sutherland D; Vitoria M; Guerma T; De Cock K
    Lancet; 2006 Aug; 368(9534):505-10. PubMed ID: 16890837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and priorities in the management of HIV/HBV and HIV/HCV coinfection in resource-limited settings.
    Easterbrook P; Sands A; Harmanci H
    Semin Liver Dis; 2012 May; 32(2):147-57. PubMed ID: 22760654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of antiretroviral failure and resistance in developing countries.
    Hawkins C; Murphy RL
    Curr Opin HIV AIDS; 2009 Nov; 4(6):538-44. PubMed ID: 20048723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in antiretroviral therapy.
    Wilkin TJ; Shalev N; Tieu HV; Hammer SM
    Top HIV Med; 2010; 18(2):66-92. PubMed ID: 20516526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to optimize HIV treatment outcomes in resource-limited settings.
    Nakanjako D; Colebunders R; Coutinho AG; Kamya MR
    AIDS Rev; 2009; 11(4):179-89. PubMed ID: 19940945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment 2.0: catalyzing the next phase of treatment, care and support.
    Duncombe C; Ball A; Passarelli C; Hirnschall G
    Curr Opin HIV AIDS; 2013 Jan; 8(1):4-11. PubMed ID: 23201857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing efficiency and costs of scaling up HIV treatment.
    Cleary SM; McIntyre D; Boulle AM
    AIDS; 2008 Jul; 22 Suppl 1():S35-42. PubMed ID: 18664951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral therapy for HIV prevention: many concerns and challenges, but are there ways forward in sub-Saharan Africa?
    Zachariah R; Harries AD; Philips M; Arnould L; Sabapathy K; O'Brien DP; Ferreyra C; Balkan S
    Trans R Soc Trop Med Hyg; 2010 Jun; 104(6):387-91. PubMed ID: 20116814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.